StoxAlkem Laboratories vs Anthem Biosciences: share price & financials comparison
NSE: ALKEM vs ANTHEM · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Alkem Laboratories vs Anthem Biosciences at a glance
Alkem Laboratories (ALKEM) has a market capitalisation of ₹61,138 Cr, against ₹52,800 Cr for Anthem Biosciences (ANTHEM). Over the past year Anthem Biosciences has returned +33.4%, compared with -9.7% for Alkem Laboratories. On valuation, Alkem Laboratories trades at a lower P/E of 29.6 versus 278.2. Alkem Laboratories earns a higher return on equity (13.9% vs 5.8%). Alkem Laboratories comes out ahead on size, valuation, profitability and growth. Anthem Biosciences comes out ahead on financial health, momentum and technicals. Across the scored metrics below, Alkem Laboratories leads on 6 and Anthem Biosciences on 6. On StoxGud's 10-point checklist, Alkem Laboratories scores 5/10 and Anthem Biosciences scores 6/10.
| Metric | Alkem Laboratories | Anthem Biosciences |
|---|---|---|
| Size | ||
| Market cap | ₹61,138 Cr | ₹52,800 Cr |
| Revenue (latest FY) | ₹14,712 Cr | ₹2,124 Cr |
| Net profit (latest FY) | ₹2,302 Cr | ₹592 Cr |
| Valuation | ||
| P/E | 29.6 | 278.2 |
| P/B | 4.11 | 16.09 |
| Dividend yield | 1.00% | — |
| Profitability | ||
| Return on equity | 13.9% | 5.8% |
| Net profit margin | 13.2% | 9.3% |
| Operating margin | 20.1% | 41.4% |
| Growth | ||
| Revenue growth (YoY) | +13.8% | +8.0% |
| Net profit growth (YoY) | -11.7% | — |
| Revenue CAGR (multi-year) | +9.9% | — |
| Financial health | ||
| Debt to equity | 0.13 | 0.01 |
| Momentum | ||
| 1-month return | -2.6% | +7.7% |
| 1-year return | -9.7% | +33.4% |
| 3-year CAGR | +5.9% | — |
| 5-year CAGR | +7.3% | — |
| 10-year CAGR | +12.0% | — |
| Distance from 52W high | -13.2% | -2.2% |
| Technicals | ||
| RSI (14) | 59 | 84 |
| Price vs 200-day avg | -5.6% | +20.2% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Alkem Laboratories | Anthem Biosciences |
|---|---|---|
| Price above 50-day average | ✗ | ✓ |
| Price above 200-day average | ✗ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✗ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 5/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Alkem Laboratories or Anthem Biosciences?
Alkem Laboratories has a market cap of ₹61,138 Cr and Anthem Biosciences has a market cap of ₹52,800 Cr as of 13 Nov 2026.
Which has a lower P/E, Alkem Laboratories or Anthem Biosciences?
Alkem Laboratories has the lower P/E: Alkem Laboratories trades at 29.6 and Anthem Biosciences at 278.2.
Which gave better returns in the last year, Alkem Laboratories or Anthem Biosciences?
Anthem Biosciences did better: Alkem Laboratories returned -9.7% and Anthem Biosciences returned +33.4% over one year.
What is the difference between Alkem Laboratories and Anthem Biosciences?
Both are NSE-listed companies in Healthcare. Alkem Laboratories is about 1.2 times the size of Anthem Biosciences by market cap. In the latest financial year Alkem Laboratories reported revenue of ₹14,712 Cr and Anthem Biosciences ₹2,124 Cr. Operating margin is 20.1% for Alkem Laboratories and 41.4% for Anthem Biosciences. Debt to equity is 0.13 for Alkem Laboratories and 0.01 for Anthem Biosciences.
Which is better, Alkem Laboratories or Anthem Biosciences?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Alkem Laboratories leads on 6 and Anthem Biosciences on 6. Alkem Laboratories is ahead on size, valuation, profitability and growth. Anthem Biosciences is ahead on financial health, momentum and technicals. On StoxGud's rules-based checklist Alkem Laboratories scores 5/10 and Anthem Biosciences scores 6/10. This is information, not advice: consult a SEBI-registered adviser before investing.